ロード中...
Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns
Pulmonary sarcoidosis involves the deposition of granulomas within the lung. These granulomas may affect lung function and lead to pulmonary symptoms, pulmonary dysfunction, functional impairment, and worsening of quality of life. Corticosteroids are generally highly effective in resolving the granu...
保存先:
| 出版年: | F1000Res |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
F1000 Research Limited
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6944258/ https://ncbi.nlm.nih.gov/pubmed/31942239 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.20696.1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|